` N4P (N4 Pharma PLC) vs FTSE All Share Index Comparison - Alpha Spread

N4P
vs
F
FTSE All Share Index

Over the past 12 months, N4P has outperformed FTSE All Share Index, delivering a return of -5% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
N4P vs FTSE All Share Index

Loading
N4P
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
N4P vs FTSE All Share Index

Loading
N4P
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
N4P vs FTSE All Share Index

Loading
N4P
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
N4 Pharma PLC vs Peers

FTSE All Share Index
N4P
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

N4 Pharma PLC
Glance View

Market Cap
4.4m GBX
Industry
Pharmaceuticals

N4 Pharma Plc is a pharmaceutical company, which engages in the reformulation of existing drugs and vaccines. The company is headquartered in Derby, Derbyshire and currently employs 5 full-time employees. The company went IPO on 2005-06-07. The firm is engaged in engaged in the development of mesoparticulate silica delivery systems to improve the cellular delivery and potency of vaccines. The company is focused on developing a delivery system for vaccines and cancer treatments using its silica nanoparticle delivery system called Nuvec. Nuvec is a non-viral adjuvant delivery system that has the potential to revolutionize vaccines and cancer treatments. The company is focused on development and commercialization of medicines via its delivery system.

N4P Intrinsic Value
0.006 GBX
Overvaluation 99%
Intrinsic Value
Price
Back to Top